authors
- Geng, Fei
- Wu, Jia-Xin
- Zhang, Hai-Hong
- Yu, Xiang-Hui
- Kong, Wei
- Bao, Xin
- Dong, Ling
- Guo, Qian-Qian
- Xie, Yu
- Zhou, Yi
- Yu, Bin
- Wu, Hui
Doxorubicin pretreatment enhances FAPα/survivin co-targeting DNA vaccine anti-tumor activity primarily through decreasing peripheral MDSCs in the 4T1 murine breast cancer model.
- Overview
- Research
- Identity
- Additional Document Info
- View All